Circulating angiopoietin-2 (Ang-2) for prediction of recurrence of atrial fibrillation

摘要

The present invention is based on determining the amount of biomarker Angiopoietin-2 (Ang-2) and optionally at least one additional biomarker in a sample from a subject, the risk of recurrence of atrial fibrillation in the subject. Relates to a method for predicting. The present invention is suspected of suffering from atrial fibrillation based on determining the amount of biomarker angiopoietin-2 (Ang-2) and optionally at least one additional biomarker in a sample from a subject. Also contemplated are methods of diagnosing atrial fibrillation in a subject. Further envisaged is an apparatus adapted to perform the method of the invention.